SCHEMBL1676238

SCHEMBL1676238

CC(=O)Oc1ccc(Cn2cc(-c3ccc(Cl)cc3Cl)nc2C=Cc2ccc(-c3cccc(C(F)(F)F)c3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 1/20 0.38
KDR P35968 2/20 0.36
EGFR P00533 1/20 0.36
IGF1R P08069 1/20 0.36
FLT4 P35916 1/20 0.36
DPP4 P27487 1/20 0.35
ICMT O60725 4/20 0.35
TEK Q02763 1/20 0.35
FNTA P49354 1/20 0.35
PGGT1B P53609 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ERBB2 P04626 1/20 0.34
PLG P00747 1/20 0.34
PLAU P00749 1/20 0.34
PLAT P00750 1/20 0.34
SPHK2 Q9NRA0 1/20 0.34
SPHK1 Q9NYA1 1/20 0.34
CNR2 P34972 1/20 0.34
GRIN2B Q13224 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1676124 0.89 S1PR5 (0.39) S1PR5KDREGFRIGF1RFLT4
SCHEMBL1676122 0.89 S1PR5 (0.39) S1PR5KDREGFRIGF1RFLT4
SCHEMBL1676754 0.89 PTGS2 (0.42) S1PR5KDREGFRIGF1RFLT4
SCHEMBL1676753 0.89 PTGS2 (0.42) S1PR5KDREGFRIGF1RFLT4
SCHEMBL1481346 0.88 DRD2 (0.44) S1PR5DPP4SMN1; SMN2PLGPLAU
SCHEMBL1481297 0.88 S1PR5 (0.38) S1PR5KDRDPP4ICMTTEK
SCHEMBL1481344 0.88 DRD2 (0.44) S1PR5DPP4SMN1; SMN2PLGPLAU
SCHEMBL1481296 0.88 S1PR5 (0.38) S1PR5KDRDPP4ICMTTEK
SCHEMBL1481124 0.88 MEN1 (0.42) S1PR5DPP4FNTAPGGT1BALDH1A1
SCHEMBL1481397 0.88 S1PR5 (0.42) S1PR5DPP4ICMTFNTAPGGT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092553-A1 Substituted Azole Derivatives, Compositions, and Methods of Use TRANSTECH PHARMA, INC. (US) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092553-A1 Substituted Azole Derivatives, Compositions, and Methods of Use PTPRO, PTPN5, PTPRE S1PR5 3261/4885KDR 2750/4885EGFR 2135/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.